Carregant...
Pharmacokinetic and Pharmacodynamic Considerations in the Design of Therapeutic Antibodies
The design and development of therapeutic monoclonal antibodies (mAbs) through optimizing their pharmacokinetic (PK) and pharmacodynamic (PD) properties is crucial to improve efficacy while minimizing adverse events. Many of these properties are interdependent, which highlights the inherent challeng...
Guardat en:
| Publicat a: | Clin Transl Sci |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6440574/ https://ncbi.nlm.nih.gov/pubmed/30414357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12597 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|